Nav: Home

California researchers awarded $100,000 Potamkin Prize for dementia research

March 23, 2017

BOSTON - The American Academy of Neurology is awarding two California researchers the 2017 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases for their work in dementia research. Claudia Kawas, MD, of the University of California, Irvine, and Kristine Yaffe, MD, of the University of California, San Francisco, both members of the American Academy of Neurology, will be honored at the American Academy of Neurology's 69th Annual Meeting in Boston.

Sometimes referred to as the Nobel Prize of Alzheimer's research, the Potamkin Prize honors researchers for their work in helping to advance the understanding of Pick's disease, Alzheimer's disease and related disorders. The $100,000 prize is an internationally recognized tribute for advancing dementia research.

Kawas and Yaffe, who work independently of each other, will be recognized for their research on the epidemiology of Alzheimer's and other dementias.

Kawas will be recognized for her dementia research on people who are 90 years old and older, called the "oldest-old." More than 1,700 people have enrolled in her 90+ Study, one of the largest studies of the oldest-old in the world. Despite being the fastest growing population segment throughout much of the world, little is known about these pioneers of aging.

"More than half of the children born in developed countries today are expected to reach their 100th birthday or more," Kawas said. "Preventing dementia and improving quality of life as we age will benefit all of us individually, as well as have an enormous public health and economic impact."

Yaffe's work focuses on the identification of modifiable risk factors, including cardiovascular and metabolic risk factors, sleep disturbances and traumatic brain injury. The results of her research in these areas highlight the critical role of modifiable risk factors, not just in late life, but across the lifespan. Her work also provides important insight into the pathways that increase dementia risk.

"Our research on modifiable risk factors for dementia prevention is important both for individual patients who are concerned about their cognitive health, and for public health prevention," Yaffe said. "Addressing these risk factors could be a fundamental component of our strategy for slowing down the dementia epidemic."

The Potamkin Prize is made possible by the philanthropic contributions of the Potamkin family of New York, Philadelphia and Miami. The goal of the prize is to help attract the best medical minds and most dedicated scientists in the world to the field of dementia research. The Potamkin family has been the Academy's single largest individual donor since 1988, providing more than $2 million to fund the Potamkin Prize.
-end-
Learn more about dementia and related diseases at http://www.aan.com/patients.

The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with 32,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussion, Parkinson's disease and epilepsy.

For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+, LinkedIn and YouTube.

Media Contacts: Renee Tessman, rtessman@aan.com, (612) 928-6137
Michelle Uher, muher@aan.com, (612) 928-6120

American Academy of Neurology

Related Neurology Articles:

BrainStorm Cell Tx publishes NurOwn ALS Phase 2 randomized trial data in neurology
Results from Brainstorm Cell Therapeutic's NurOwn randomized Phase 2 clinical trial were published in Neurology.
The Lancet Neurology: Pioneering study suggests that an exoskeleton for tetraplegia could be feasible
A whole-body exoskeleton, operated by recording and decoding brain signals, has helped a tetraplegic patient to move all four of his paralysed limbs, according to results of a 2-year trial published in The Lancet Neurology journal.
The Lancet Neurology: Frailty could make people more susceptible to dementia
New research published in The Lancet Neurology journal suggests that frailty makes older adults more susceptible to Alzheimer's dementia, and moderates the effects of dementia-related brain changes on dementia symptoms.
The Lancet Neurology: Cannabis-based drug in combination with other anti-spasticity
Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs.
New neurology studies a 'wakeup call' for global health
Neurology experts from around the world will convene Nov. 27 in New Zealand for a Global Brain Summit examining what one calls 'the greatest challenge of societies in the 21st century.' Among the neurological disorders to be discussed at the Summit are stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and migraine and other headaches.
The Lancet Neurology: Daily and weekly cycles of epileptic seizures more common than previously thought
Understanding the pattern of seizures, and how they are linked to circadian rhythms, could be important in improving management of epilepsy.
Do men outnumber women in academic neurology programs?
Men outnumbered women at all faculty levels in top-ranked academic neurology programs, findings that are consistent with previous studies of both neurology and other specialties.
What are the financial barriers to adherence to treatment in neurology?
Though there is a growing armamentarium of medical therapies to treat neurological disease, patient adherence to taking the medication is critical to their effectiveness.
Nanomaterials for neurology: State-of-the-art
Despite the numerous challenges associated with the application of nanotechnology in neuroscience, it promises to have a significant impact on our understanding of how the nervous system works, how it fails in disease, and the development of earlier and less-invasive diagnostic procedures so we can intervene in the preclinical stage of neurological disease before extensive neurological damage has taken place.
Loyola neurologist is co-author and editor of four new neurology textbooks
Loyola Medicine neurologist José Biller, M.D., is a co-author, editor and co-editor of new editions of four major neurology textbooks that are helping physicians keep abreast with the ever expanding knowledge of neurological diseases and disorders.
More Neurology News and Neurology Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab